FAAH, fatty acid amide hydrolase, 2166

N. diseases: 177; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.350 GeneticVariation group BEFREE Enhanced brain levels of anandamide after treatment with inhibitors of fatty acid amide hydrolase, the main enzyme responsible for its degradation, seem to affect the rewarding and reinforcing actions of many drugs of abuse. 30050084 2019
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.350 Biomarker group BEFREE Importantly, FAAH blockade does not elicit any apparent psychomimetic effects associated with THC or produce reinforcing effects that are predictive of human drug abuse. 19184452 2009
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.350 Biomarker group CTD_human Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. 19103437 2009
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.350 GeneticVariation group BEFREE Although a link between the FAAH P129T variant and human drug abuse has been reported, the extent of risk and specific types of substance addiction vulnerability remain to be determined. 16972078 2006
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.350 GeneticVariation group BEFREE These findings indicate that the natural 385A SNP in the human FAAH gene produces a mutant enzyme with reduced cellular stability, thus fortifying a potential link between functional abnormalities in the endocannabinoid system and drug abuse and dependence. 15254019 2004
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.350 Biomarker group CTD_human Collectively, these results suggest that genetic mutations in FAAH may constitute important risk factors for problem drug use and support a potential link between functional abnormalities in the endogenous cannabinoid system and drug abuse and dependence. 12060782 2002
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.350 GeneticVariation group BEFREE Collectively, these results suggest that genetic mutations in FAAH may constitute important risk factors for problem drug use and support a potential link between functional abnormalities in the endogenous cannabinoid system and drug abuse and dependence. 12060782 2002